Special Issue "Gastroenterological Aspects of COVID-19 Infection"

A special issue of Gastroenterology Insights (ISSN 2036-7422).

Deadline for manuscript submissions: 31 March 2022.

Special Issue Editors

Dr. Tsvetelina Velikova
E-Mail Website
Guest Editor
University Hospital Lozenetz, Sofia University St. Kliment Ohridski, Kozyak 1 str, 1407 Sofia, Bulgaria
Interests: autoimmunity; celiac disease; IBD; mucosal immunity; inflammation; cytokines; T cell immunity; microbiome; COVID-19
Dr. Radislav Nakov
E-Mail Website
Guest Editor
Clinic of Gastroenterology, Tsaritsa Joanna University Hospital, Medical University of Sofia, 1527 Sofia, Bulgaria
Interests: IBD; neurogatroenterology; endoscopy; IBS; colonoscopy; microbiome; FMT; transthyretin amyloidosis; xenobiotics

Special Issue Information

Dear Colleagues,

The gastrointestinal tract is one of the most vulnerable to SARS-CoV-2 infection systems. As the first line for physical and immunological defense, the intestinal immune system is essential since the gastrointestinal tract can also be a crucial entrance or an interaction site during COVID-19. In addition, patients with gastrointestinal disorders have been associated with poorer clinical outcomes after infection. The liver can also be damaged by the virus or drugs used for treatment.

This Special Issue is devoted to recent and novel insights and perspectives regarding virus–immune cells interactions, immunological mechanisms and processes inside the intestinal mucosa throughout the illness, the involvement of the gastrointestinal tract in SARS-CoV-2 infection, symptoms, complications, therapeutic options, the role of the microbiome in the infection, vaccination for people with gastrointestinal diseases, etc.

Dr. Tsvetelina Velikova
Dr. Radislav Nakov
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gastroenterology Insights is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • SARS-CoV-2
  • COVID-19
  • mucosa
  • gut mucosa
  • ACE II
  • mucosa-associated lymphoid tissue
  • secretory immunoglobulin A
  • gut microbiota
  • gastrointestinal disorders
  • gastrointestinal symptoms
  • treatment
  • COVID-19 vaccine
  • liver failure
  • drug-induced live injury

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Review
COVID-19 and the Gastrointestinal Tract
Gastroenterol. Insights 2021, 12(4), 394-404; https://0-doi-org.brum.beds.ac.uk/10.3390/gastroent12040038 - 24 Oct 2021
Viewed by 712
Abstract
Since it was discovered at the end of 2019; the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide, with over 175 million confirmed cases reported globally. Even [...] Read more.
Since it was discovered at the end of 2019; the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide, with over 175 million confirmed cases reported globally. Even when COVID-19 was initially considered a respiratory disease, it was actually known to be multisystemic, with gastrointestinal involvement a common clinical finding. Furthermore, COVID-19 may affect patients with gastrointestinal comorbidities, being the clinical intersectionality of utmost interest for gastroenterologists; critical care physicians and all the healthcare team taking care of COVID-19 patients. The present article presents a brief review of the reported gastrointestinal manifestations of COVID-19 disease in both previously healthy individuals and in patients with gastrointestinal comorbidities. Full article
(This article belongs to the Special Issue Gastroenterological Aspects of COVID-19 Infection)
Show Figures

Figure 1

Back to TopTop